Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
FRENCH pharmaceutical group Sanofi said it has obtained the right to develop and sell a new haemophilia drug in a restructuring of its partnership with Alnylam Pharmaceuticals.
Under the agreement, Sanofi will obtain global development and commercialisation rights to...